Pubblicazioni

COVID pandemic and denosumab adherence

2022 - OSTEOPOROSIS INTERNATIONAL

Minisola, S; Cipriani, C; Vigna, E; Sonato, C; Colangelo, L; Monti, F; Pepe, J

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

2015 - OSTEOPOROSIS INTERNATIONAL

Papapoulos, S; Lippuner, ; Roux, C; Lin, C. J. F.; Kendler, D. L.; Lewieck, E. M.; Brandi, M. L.; CzerwiÅski, E.; Franek, E.; Lakatos, P.; Mautalen, C.; Minisola, Salvatore; Reginster, J. Y.; Jensen, S.; Daizadeh, N. S.; Wang, A.; Gavin, M.; Libanati, C.; Wagman, R. B.; Bone, H. G.